Is requiring incentive spirometry, EzPAP (positive airway pressure device), and Acapella (airway clearance device) for all patients breathing room air without a history of respiratory disease medically justified, or could it constitute Medicare fraud?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Requiring IS, EzPAP, and Acapella for All Patients Without Respiratory Disease is NOT Medically Justified

This practice lacks any evidence-based medical indication and constitutes inappropriate use of respiratory therapy devices that should only be prescribed for specific clinical conditions, not as routine "wellness" interventions.

The Evidence Against Routine Use

Incentive Spirometry

The evidence is clear and consistent:

  • Incentive spirometry is explicitly NOT recommended for routine prophylactic use in postoperative patients 1. The 2011 AARC clinical practice guideline states that IS alone should not be used routinely to prevent postoperative pulmonary complications.

  • For hospitalized patients without cystic fibrosis, airway clearance therapy is NOT recommended if the patient can mobilize secretions with cough 2. This applies to your room air patients with no respiratory disease.

  • The guideline specifically states: "ACT is not recommended for routine postoperative care" 2.

Airway Clearance Devices (Acapella)

The 2006 ACCP evidence-based guidelines are explicit about appropriate populations 3:

  • These devices are indicated for patients with mucus hypersecretion (particularly cystic fibrosis, bronchiectasis, COPD with symptomatic secretion retention)
  • They are for patients with neuromuscular disease and impaired cough
  • There is no evidence supporting their use in healthy patients without respiratory disease

The guideline emphasizes these techniques are "well-entrenched in the management of patients with mucus hypersecretion" - not healthy individuals 3.

EzPAP (Positive Airway Pressure)

Recent evidence shows EzPAP has specific indications 4, 5:

  • Hypercapnic COPD exacerbations
  • Critically ill patients with atelectasis and worsened PaO2/FiO2
  • Not for routine use in healthy patients on room air

The Medical Standard of Care

What Guidelines Actually Recommend

For patients without respiratory symptoms or disease, the medical standard is:

  • Early mobility and ambulation to prevent postoperative complications 2
  • Deep breathing exercises and effective cough technique instruction (which don't require expensive devices) 1
  • No routine respiratory therapy devices

The Screening Problem

The USPSTF explicitly recommends against screening asymptomatic adults for COPD using spirometry (Grade D recommendation) 6. The rationale:

  • Even in high-risk populations, 455 adults would need to be screened to defer 1 exacerbation 6
  • The opportunity costs are large with no net benefit 6
  • This applies to healthy adults who do not recognize or report respiratory symptoms 6

If we shouldn't even screen asymptomatic patients, prescribing treatment devices makes even less sense.

The Fraud Concern

Why This Raises Red Flags

Billing Medicare for medically unnecessary services is the definition of fraud. The elements present here:

  1. No medical indication: Room air patients without respiratory disease have no evidence-based need for these devices
  2. Blanket ordering: Applying therapy to "all patients" regardless of clinical assessment violates individualized care standards
  3. Financial motivation: Framing this as a "wellness program" while billing Medicare suggests revenue generation rather than medical necessity
  4. Administrative pressure: Admin pushing clinical decisions typically indicates business rather than medical priorities

The Medical Necessity Standard

Medicare requires:

  • Services must be reasonable and necessary for diagnosis or treatment
  • Must be consistent with accepted standards of medical practice
  • Cannot be more costly than alternative services that are equally effective

None of these criteria are met for routine IS/EzPAP/Acapella in healthy patients.

Common Pitfalls to Avoid

The "It Can't Hurt" Fallacy

Even if these devices were harmless (they're not risk-free), billing for unnecessary services is problematic:

  • Opportunity costs are real harms 6
  • False-positive findings lead to unnecessary follow-up 6
  • Device-related adverse effects exist (though rare)
  • Financial harm to Medicare and beneficiaries

The "Wellness Program" Disguise

Calling something a "wellness program" doesn't make it medically necessary. Medicare doesn't pay for:

  • Unproven preventive interventions
  • Services without evidence of benefit
  • Routine application of treatment devices to healthy individuals

Your Position as the Rounding Provider

You are correct to question this practice. Your clinical judgment should guide orders, not administrative mandates. Consider:

  1. Document your medical decision-making: Note when these devices are NOT indicated
  2. Order only when medically necessary: Specific indications like postoperative high-risk patients, symptomatic secretion retention, neuromuscular weakness
  3. Educate administration: Share these guidelines showing lack of evidence
  4. Consult compliance/legal: If pressured to order unnecessary services, this is an institutional compliance issue

When These Devices ARE Appropriate

Order IS/EzPAP/Acapella only for:

  • Postoperative high-risk patients (upper abdominal surgery, thoracic surgery) - and even then, combined with early mobility and deep breathing 1
  • COPD patients with symptomatic secretion retention 2
  • Neuromuscular disease with impaired cough (peak cough flow <270 L/min) 2
  • Critically ill patients with atelectasis and hypoxemia 5
  • Hypercapnic respiratory failure (EzPAP specifically) 4

Not for healthy patients on room air without respiratory disease history.

References

1
Research

Incentive spirometry: 2011.

Respiratory care, 2011

Related Questions

Which patients does the American College of Chest Physicians (ACCP) recommend the use of incentive spirometry (IS), EzPAP, or Acapella (oscillating positive expiratory pressure device) in?
Should incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory airway clearance device) be used routinely for a general skilled nursing facility or long‑term care patient population who are breathing room air, have no history of pulmonary disease, and are only limited by reduced activity?
Which diseases do respiratory societies recommend the use of incentive spirometry, EzPAP, or Acapella, and should these devices be used in patients admitted to a skilled‑nursing facility who have no history of lung disease?
Can an incentive spirometer be used for chest physiotherapy after thyroidectomy?
Is it appropriate to prescribe EzPAP (EzPAP device) for all residents in a skilled‑nursing or long‑term‑care facility as a blanket preventive measure regardless of diagnosis, and can it be billed under Medicare Part A?
Does a child weighing 62.8 kg qualify for adult dosing?
What is the appropriate antihypertensive management for a 49-year-old Black male with persistent stage 2 hypertension (blood pressure ~152/111 mm Hg) after discontinuing hydrochlorothiazide (HCTZ)?
What are the various investigations for upper gastrointestinal bleeding and the indications for using each?
In a 76-year-old patient with a serum creatinine of 0.56 mg/dL and a BUN/creatinine ratio of 23, what is the appropriate management?
In a 71‑year‑old woman with hypertension, type 2 diabetes, prior intracerebral hemorrhage, anemia, and recent memory decline who presents with an infected lower‑extremity amputation stump, what is the recommended management?
What is the CPT code for a robot-assisted minimally invasive Ivor Lewis esophagectomy performed for distal esophageal adenocarcinoma in a patient on postoperative day 3?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.